Biotech MavenHot Analyst Reads4 Hot Analyst Reads For Friday, July 13thBiotech MavenZynerba Pharmaceuticals Received its Third Buy in a Row - MarketsAfter Cantor Fitzgerald and Canaccord Genuity gave Zynerba Pharmaceuticals (NASDAQ: ZYNE) a Buy rating last month, the company received anotherwww.markets.co
